Question: A 48-year-old man was admitted to emergency department because of left upper abdominal pain for 3 weeks and yellow urine for 1 week. The patient was diagnosed with splenic hemangioma for 3 years and recurrent epistaxis for 5 years, without further treatment. Physical examination showed tenderness and rebound pain in the left upper abdomen, no muscle tension, with shifting dullness. Laboratory studies showed a neutrophil count of 8990/mm3 (reference range, 1900–8000/mm3), a hemoglobin level of 66 g/L (reference range, 131–172 g/L), a total bilirubin level of 57.23 μmol/L (reference range, 5.1–20 μmol/L), a serum alanine aminotransferase level of 302.9 U/L (reference range, 9–50 U/L), a serum aspartate aminotransferase level of 117.5 U/L (reference range, 15–40 U/L), an activated partial prothrombin time of 34.6 (reference range, 25–34), and a quantitative D-dimer level of 361.23 (reference range, 0–0.55). Emergency abdominal computed tomography scan showed diffuse hepatic and splenic vascular malformations (Figure A), and a ruptured splenic tumor (Figure B, arrow). It is worth noting that the patient's father had the same disease during his lifetime after asking about the family history. What is the most likely diagnosis? Look on page 808 for the answer and see the Gastroenterology website (www.gastrojournal.org) for more information on submitting your favorite image to Clinical Challenges and images in GI. After consultation with the patient, he underwent emergency splenectomy and liver biopsy. Histopathology demonstrated the dilatation of hepatic capillaries, showing hemangioma-like changes (Figure C). The ruptured splenic tumor was confirmed pathologically as hemangioendothelioma. After a multidisciplinary consultation, the patient was diagnosed with hereditary hemorrhagic telangiectasia (HHT) according to the Curaçao criteria.1Faughnan M.E. Palda V.A. Garcia-Tsao G. et al.International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia.J Med Genet. 2011; 48: 73-87Crossref PubMed Scopus (745) Google Scholar HHT, also called Osler–Weber–Rendu disease, is an autosomal-dominant disease. Up to one-third of patients have hepatic involvement and manifest as vascular malformations,2Chung D.Y. Federle M.P. Barrett J.P. et al.Hepatic hereditary hemorrhagic telangiectasia.Clin Gastroenterol Hepatol. 2006; 4 (xx)Abstract Full Text Full Text PDF Scopus (1) Google Scholar such as hepatic arteriovenous fistula (Figure D, rectangle). Martini3Martini G.A. The liver in hereditary haemorrhagic teleangiectasia: an inborn error of vascular structure with multiple manifestations: a reappraisal.Gut. 1978; 19: 531-537Crossref PubMed Scopus (95) Google Scholar classified patients with hepatic disease due to HHT into 3 subgroups: patients who had telangiectases with fibrosis or cirrhosis (as in our case), those who had cirrhosis without telangiectases, and those who had telangiectases without fibrosis or cirrhosis. Treatment is mostly supportive, but severe patients may require hepatic artery embolization or liver transplantation.2Chung D.Y. Federle M.P. Barrett J.P. et al.Hepatic hereditary hemorrhagic telangiectasia.Clin Gastroenterol Hepatol. 2006; 4 (xx)Abstract Full Text Full Text PDF Scopus (1) Google Scholar During the period of waiting for liver transplantation, the patient developed hepatic and renal insufficiency and respiratory failure. On day 11 of hospitalization, the patient's family asked to be transferred back to the local hospital for treatment. The patient died of multiple organ failure on the third day after transfer.